Bright Minds Biosciences (DRUG) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free DRUG Stock Alerts $1.11 +0.04 (+3.74%) (As of 01:11 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative January 12, 2024 | msn.comPsyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And MoreDecember 6, 2023 | finance.yahoo.comBright Minds Announces Non-Brokered Private Placement Fully Subscribed by ManagementNovember 12, 2023 | msn.comPsyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & MoreNovember 12, 2023 | finance.yahoo.comBright Minds Biosciences Inc. (DRUG.CN)October 25, 2023 | benzinga.comBright Minds Biosciences Stock (NASDAQ:DRUG) Dividends: History, Yield and DatesAugust 18, 2023 | seekingalpha.comDRUG Bright Minds Biosciences Inc.August 8, 2023 | msn.comBright Minds stock rallies ahead of conference call to discuss Phase 1 dataAugust 8, 2023 | finance.yahoo.comBright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101August 7, 2023 | msn.comBright Minds reports results from trial to treat refractory epilepsiesJuly 24, 2023 | benzinga.comCybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical TrialsJuly 20, 2023 | finance.yahoo.comBright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101July 12, 2023 | benzinga.comBright Minds Biosciences Stock (NASDAQ:DRUG), Short Interest ReportJuly 11, 2023 | msn.comBright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ ComplianceJuly 11, 2023 | finanznachrichten.deBright Minds Biosciences: Bright Minds Announces Effective Date of Share ConsolidationJune 22, 2023 | finanznachrichten.deBright Minds Biosciences: Bright Minds Announces Proposed Share ConsolidationJune 22, 2023 | finance.yahoo.comBright Minds Announces Proposed Share ConsolidationMay 16, 2023 | benzinga.comBright Minds Biosciences Stock (NASDAQ:DRUG), Earnings Estimates, EPS, and RevenueApril 20, 2023 | benzinga.comBright Minds Biosciences Stock (NASDAQ:DRUG), Analyst Ratings, Price Targets, PredictionsApril 19, 2023 | benzinga.comBright Minds Biosciences Stock (NASDAQ:DRUG), Trade IdeasApril 19, 2023 | finance.yahoo.comBright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202April 10, 2023 | finance.yahoo.comBright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin ResearchFebruary 27, 2023 | finance.yahoo.comBright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023February 8, 2023 | finance.yahoo.comBright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee RequirementsJanuary 27, 2023 | finance.yahoo.comBright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyDecember 2, 2022 | finance.yahoo.comBright Minds Biosciences Announces Closing of Non-Brokered Private PlacementNovember 28, 2022 | finance.yahoo.comBright Minds Biosciences Announces Non-Brokered Private PlacementNovember 23, 2022 | finance.yahoo.comBright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical OfficerOctober 18, 2022 | benzinga.comThinking about buying stock in Akouos, Federated National, Bright Minds Biosciences, VNET Group, or MFA Financial?September 26, 2022 | finance.yahoo.comBright Minds Biosciences Inc. (DRUG)September 7, 2022 | finance.yahoo.comBright Minds Biosciences Announces Appointment of Doug Williamson to Board of DirectorsAugust 31, 2022 | marketwatch.comBright Minds Biosciences Shares Drop 22% After Epileptic Drug Dosing, Closed OfferingAugust 31, 2022 | benzinga.comNasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For EpilepsyAugust 31, 2022 | finance.yahoo.comBright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet SyndromeAugust 30, 2022 | finance.yahoo.comBright Minds Biosciences Announces Closing of $4 Million Unit OfferingAugust 27, 2022 | marketwatch.comThinking about buying stock in Bright Minds Biosciences, Futu Holdings, Zhihu, Tencent Music Entertainment, or IQIYI?August 23, 2022 | finance.yahoo.comBright Minds Announces Pricing of Overnight Marketed Offering of UnitsAugust 22, 2022 | finance.yahoo.comBright Minds Announces Overnight Marketed Offering of UnitsAugust 22, 2022 | barrons.comBright Minds Biosciences Inc.August 18, 2022 | finance.yahoo.comBright Minds Biosciences Comments on Recent Trading ActivityAugust 18, 2022 | marketbeat.comTrading was temporarily halted for "DRUG" at 09:08 AM with a stated reason of "LULD pause."August 18, 2022 | marketbeat.comTrading was temporarily halted for "DRUG" at 09:08 AM with a stated reason of "LULD pause."June 27, 2022 | seekingalpha.comBright Minds Biosciences names Jan Torleif Pedersen as interim science chiefJune 27, 2022 | finance.yahoo.comBright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development OrganizationMay 12, 2022 | finance.yahoo.comBright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet SyndromeMay 2, 2022 | investing.comBright Minds Biosciences Inc (DRUG)April 27, 2022 | finance.yahoo.comBright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental DiseasesApril 27, 2022 | finance.yahoo.comBright Minds Biosciences to Present at the Stifel GMP 2nd Annual Future of Healthcare ConferenceApril 27, 2022 | finance.yahoo.comCanadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing MilestoneApril 27, 2022 | finance.yahoo.comBright Minds Biosciences to Present at the H.C. Wainwright Bioconnect ConferenceApril 27, 2022 | finance.yahoo.comBright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address [URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over? Click here for our #1 AI Stock for 2024 and Beyond DRUG Media Mentions By Week DRUG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRUG News Sentiment▼1.610.56▲Average Medical News Sentiment DRUG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRUG Articles This Week▼30▲DRUG Articles Average Week Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Petros Pharmaceuticals News Today China Pharma News Today Lipella Pharmaceuticals News Today Kazia Therapeutics News Today ZyVersa Therapeutics News Today Seelos Therapeutics News Today NexImmune News Today GT Biopharma News Today Tharimmune News Today Exicure News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRUG) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
